Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON31283Not yet recruiting
Open-label trial of hydrochlorothiazide in hypertension (HTN) (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in ADH-AQP2 ratio. Planned start Aug 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON31283.